News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245,369 Results
Type
Article (7232)
Company Profile (26)
Press Release (238111)
Section
Business (88275)
Career Advice (549)
Deals (15627)
Drug Delivery (12)
Drug Development (21059)
Employer Resources (32)
FDA (4010)
Job Trends (4367)
News (129225)
Policy (8279)
Tag
2024 BioCapital Digital (3)
2024 BioMidwest Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (615)
Academic (1)
Accelerated approval (2)
Adcomms (4)
Allergies (12)
Alliances (17272)
ALS (20)
Alzheimer's disease (276)
Antibody-drug conjugate (ADC) (12)
Approvals (4024)
Artificial intelligence (51)
Autoimmune disease (2)
Automation (2)
Bankruptcy (108)
Best Places to Work (3200)
BIOSECURE Act (2)
Biosimilars (11)
Biotechnology (27)
Bladder cancer (10)
Brain cancer (8)
Breast cancer (51)
Cancer (466)
Cardiovascular disease (22)
Career advice (467)
Career pathing (5)
CAR-T (34)
Cell therapy (119)
Cervical cancer (2)
Clinical research (17464)
Collaboration (209)
Compensation (153)
Complete response letters (2)
COVID-19 (516)
CRISPR (11)
C-suite (97)
Cystic fibrosis (17)
Data (541)
Decentralized trials (1)
Denatured (3)
Depression (6)
Diabetes (42)
Diagnostics (2245)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (26)
Drug pricing (9)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (41366)
Editorial (1)
Employer branding (7)
Employer resources (32)
Events (39954)
Executive appointments (304)
FDA (4266)
Featured Employer (7)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (212)
Gene editing (20)
Generative AI (3)
Gene therapy (52)
GLP-1 (118)
Government (652)
Guidances (16)
Healthcare (5544)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (17)
Indications (6)
Infectious disease (542)
Inflammatory bowel disease (26)
Inflation Reduction Act (2)
Influenza (9)
Intellectual property (21)
Interviews (63)
IPO (8018)
IRA (4)
Job creations (1264)
Job search strategy (432)
Kidney cancer (6)
Labor market (5)
Layoffs (110)
Leadership (6)
Legal (2431)
Liver cancer (18)
Lung cancer (53)
Lymphoma (34)
Management (10)
Manufacturing (56)
MASH (27)
Medical device (4223)
Medtech (4224)
Mergers & acquisitions (7799)
Metabolic disorders (121)
Multiple sclerosis (9)
NASH (6)
Neurodegenerative disease (12)
Neuropsychiatric disorders (1)
Neuroscience (374)
NextGen: Class of 2025 (1883)
Non-profit (1040)
Northern California (911)
Now hiring (2)
Obesity (54)
Opinion (38)
Ovarian cancer (17)
Pain (15)
Pancreatic cancer (13)
Parkinson's disease (23)
Partnered (7)
Patents (30)
Patient recruitment (28)
Peanut (6)
People (26884)
Pharmaceutical (7)
Pharmacy benefit managers (1)
Phase I (5295)
Phase II (7658)
Phase III (5942)
Pipeline (531)
Podcasts (3)
Policy (12)
Postmarket research (656)
Preclinical (2164)
Press Release (70)
Prostate cancer (26)
Psychedelics (3)
Radiopharmaceuticals (106)
Rare diseases (71)
Real estate (2146)
Recruiting (9)
Regulatory (5591)
Reports (15)
Research institute (659)
Resumes & cover letters (77)
Rett syndrome (3)
RSV (1)
Schizophrenia (21)
Series A (30)
Series B (23)
Service/supplier (1)
Sickle cell disease (8)
Southern California (702)
Special edition (1)
Spinal muscular atrophy (38)
Sponsored (3)
Startups (1219)
Stomach cancer (1)
Supply chain (12)
United States (7228)
Vaccines (74)
Venture capitalists (5)
Webinars (5)
Weight loss (20)
Women's health (5)
Date
Today (30)
Last 7 days (255)
Last 30 days (965)
Last 365 days (11124)
2025 (2752)
2024 (11907)
2023 (14240)
2022 (20045)
2021 (21269)
2020 (20046)
2019 (14690)
2018 (11375)
2017 (11323)
2016 (10426)
2015 (13513)
2014 (10676)
2013 (8691)
2012 (9103)
2011 (9693)
2010 (9404)
Location
Africa (220)
Alabama (15)
Alaska (2)
Arizona (60)
Arkansas (1)
Asia (12601)
Australia (1868)
California (1921)
Canada (715)
China (79)
Colorado (83)
Connecticut (96)
Delaware (29)
Europe (27007)
Florida (270)
Georgia (73)
Idaho (24)
Illinois (120)
India (6)
Indiana (60)
Iowa (1)
Japan (65)
Kansas (27)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (232)
Massachusetts (1564)
Michigan (89)
Minnesota (156)
Mississippi (1)
Missouri (31)
Montana (16)
Nebraska (12)
Nevada (22)
New Hampshire (16)
New Jersey (580)
New Mexico (6)
New York (509)
North Carolina (334)
North Dakota (3)
Northern California (911)
Ohio (67)
Oklahoma (5)
Oregon (4)
Pennsylvania (365)
Rhode Island (18)
South America (318)
South Carolina (5)
Southern California (702)
Tennessee (39)
Texas (238)
Utah (57)
Virginia (49)
Washington D.C. (11)
Washington State (168)
West Virginia (2)
Wisconsin (21)
245,369 Results for "calypte biomedical corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Press Releases
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 28, 2025
·
11 min read
Press Releases
Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on Thursday, March 27, 2025
March 12, 2025
·
2 min read
Press Releases
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update
January 2, 2025
·
18 min read
Press Releases
Bleichmar Fonti & Auld LLP Announces a Proposed Settlement in the In re Talis Biomedical Corporation Securities Litigation
December 23, 2024
·
4 min read
Press Releases
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences
February 27, 2025
·
2 min read
Business
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 9, 2024
·
8 min read
Press Releases
Patricia Industries’ subsidiary Advanced Instruments to acquire and merge with Nova Biomedical
March 19, 2025
·
5 min read
Partnered
Making the Grade: Drexel’s Biomedical Sciences Programs Boost Careers at All Stages
At Drexel University’s Graduate School of Biomedical Sciences and Professional Studies, graduate students and active professionals can take interdisciplinary, career-oriented programs designed to help launch their careers and take them to the next level.
December 3, 2024
·
5 min read
·
BioSpace Insights
Press Releases
Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit
March 21, 2025
·
7 min read
1 of 24,537
Next
